Akumin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Akumin and buy or sell other stocks, ETFs, and their options commission-free!

About AKU

Akumin, Inc. engages in the provision of fixed-site outpatient diagnostic imaging services and solutions. It operates under the Radiology and Oncology segments. 

CEO
Henry Howe, MBA
CEOHenry Howe, MBA
Employees
Employees
Headquarters
Plantation, Florida
HeadquartersPlantation, Florida
Founded
2015
Founded2015
Employees
Employees

AKU Key Statistics

Market cap
34.19M
Market cap34.19M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
Dividend yield
Average volume
594.99K
Average volume594.99K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.30
52 Week high$1.30
52 Week low
$0.1177
52 Week low$0.1177

Stock Snapshot

With a market cap of 34.19M, Akumin(AKU) trades at $1.51. The stock has a price-to-earnings ratio of -0.13.

On 2026-05-06, Akumin(AKU) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Akumin(AKU) stock has reached 0, versus its average volume of 594.99K.

Over the past 52 weeks, Akumin(AKU) stock has traded between a high of $1.30 and a low of $0.12.

Over the past 52 weeks, Akumin(AKU) stock has traded between a high of $1.30 and a low of $0.12.

People also own

Based on the portfolios of people who own AKU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.